In adult patients with CML, pathogenic somatic cytogenetic aberrations and SNVs in addition to the disease‐driving BCR::ABL1 fusion gene have been extensively investigated in numerous studies. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.